We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 14.89%
This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$817M
AUM Growth
-$36.2M
Cap. Flow
-$39.4M
Cap. Flow %
-4.82%
Top 10 Hldgs %
12.04%
Holding
1,060
New
418
Increased
118
Reduced
111
Closed
413

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$12.8M
2
CRM icon
Salesforce
CRM
+$9.18M
3
NKE icon
Nike
NKE
+$8.85M
4
DHR icon
Danaher
DHR
+$8.43M
5
AMZN icon
Amazon
AMZN
+$8.08M

Top Sells

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$17.9M
2
TSLA icon
Tesla
TSLA
+$16.6M
3
CVX icon
Chevron
CVX
+$15.3M
4
MDB icon
MongoDB
MDB
+$9.4M
5
FTNT icon
Fortinet
FTNT
+$8.82M

Sector Composition

Rank Sector Weight
1 Technology 22.57%
2 Consumer Discretionary 15.97%
3 Healthcare 14.57%
4 Industrials 11.33%
5 Financials 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APH icon
76
Amphenol
APH
$199B
$3.03M 0.37%
+43,600
New +$3.05M
SNAP icon
77
Snap
SNAP
$9.01B
$3.01M 0.37%
+279,400
New +$3.15M
UNH icon
78
UnitedHealth
UNH
$355B
$2.89M 0.35%
+5,707
New +$3.24M
LHX icon
79
L3Harris
LHX
$48.8B
$2.88M 0.35%
13,684
+3,100
+29% +$743K
CVNA icon
80
Carvana
CVNA
$53.3B
$2.87M 0.35%
+70,555
New +$3.17M
GTLS
81
DELISTED
Chart Industries
GTLS
$2.82M 0.35%
14,772
+9,200
+165% +$1.48M
ACN icon
82
Accenture
ACN
$115B
$2.81M 0.34%
+8,000
New +$2.88M
ZBH icon
83
Zimmer Biomet
ZBH
$19B
$2.81M 0.34%
26,607
+22,900
+618% +$2.46M
GM icon
84
General Motors
GM
$75.6B
$2.78M 0.34%
52,200
-24,058
-32% -$1.26M
BF.B icon
85
Brown-Forman Class B
BF.B
$12.5B
$2.76M 0.34%
+72,600
New +$3.19M
BBWI icon
86
Bath & Body Works
BBWI
$3.76B
$2.72M 0.33%
+70,179
New +$2.35M
AKAM icon
87
Akamai
AKAM
$16B
$2.7M 0.33%
28,258
+17,207
+156% +$1.69M
SHEL icon
88
Shell
SHEL
$250B
$2.63M 0.32%
42,000
+29,800
+244% +$1.95M
HES
89
DELISTED
Hess
HES
$2.58M 0.32%
19,400
-25,600
-57% -$3.57M
SKX
90
DELISTED
Skechers
SKX
$2.54M 0.31%
+37,800
New +$2.45M
NU icon
91
Nu Holdings
NU
$71.9B
$2.52M 0.31%
+243,000
New +$3.23M
DD icon
92
DuPont de Nemours
DD
$18.7B
$2.51M 0.31%
26,276
+5,019
+24% +$522K
P
93
Everpure Inc
P
$33B
$2.5M 0.31%
+40,700
New +$2.27M
EXPD icon
94
Expeditors International
EXPD
$24.8B
$2.48M 0.3%
+22,427
New +$2.68M
AMAT icon
95
Applied Materials
AMAT
$383B
$2.47M 0.3%
+15,200
New +$2.75M
CVE icon
96
Cenovus Energy
CVE
$58.5B
$2.47M 0.3%
163,000
+90,700
+125% +$1.46M
TT icon
97
Trane Technologies
TT
$100B
$2.44M 0.3%
6,600
+1,068
+19% +$424K
LEA icon
98
Lear
LEA
$8.23B
$2.41M 0.29%
25,427
+7,100
+39% +$707K
CTSH icon
99
Cognizant
CTSH
$28.7B
$2.36M 0.29%
+30,700
New +$2.4M
ENB icon
100
Enbridge
ENB
$109B
$2.32M 0.28%
+54,700
New +$2.29M

Similar funds

Bayesian Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Bayesian Capital Management held 1,060 positions worth $817M, down 4.2% from $853M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Bayesian Capital Management withdrew a net $39.4M in Q4 2024, closing 413 positions and reducing 111 holdings. Its most notable exit was Netflix, an estimated $17.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Bayesian Capital Management opened a new position in Amgen worth $11.2M.

  • Bayesian Capital Management's largest Q4 2024 buy was Amgen: 43,000 shares worth $11.2M.
  • Bayesian Capital Management added most to Nike in Q4 2024, an estimated $8.85M increase.
  • Bayesian Capital Management's biggest Q4 2024 reduction was Tesla, cutting an estimated $16.6M.
  • Bayesian Capital Management fully exited Netflix in Q4 2024, selling an estimated $17.9M.
  • Bayesian Capital Management's ten largest holdings make up 12% of its $817M portfolio in Q4 2024.
  • Bayesian Capital Management opened 418 new positions and closed 413 in Q4 2024.
  • Bayesian Capital Management's portfolio value fell 4.2% quarter-over-quarter to $817M.

Based on Bayesian Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.